Nanobac Pharmaceuticals Incorporated (NNBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2006 | 06-2006 | 03-2006 | 12-2005 | 09-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 110 | 180 | 620 | 9 | 10 |
| Receivables | 9 | 5 | 10 | 3 | 10 |
| Inventories | 110 | 110 | 100 | 110 | 60 |
| Other current assets | 31 | 35 | 50 | 48 | 60 |
| TOTAL | $260 | $330 | $780 | $170 | $140 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 7,750 | 7,810 | 7,920 | 8,680 | 8,860 |
| TOTAL | $7,750 | $7,810 | $7,920 | $8,680 | $8,860 |
| Total Assets | $8,090 | $8,220 | $8,790 | $8,970 | $9,130 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 320 | 370 | 270 | 310 | 490 |
| Accrued Expenses | 580 | 720 | 880 | 840 | 590 |
| Other current liabilities | 9 | 10 | 20 | 20 | 30 |
| TOTAL | $5,590 | $5,130 | $4,860 | $3,660 | $3,000 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,830 | 2,830 | 2,830 | 2,830 | 2,910 |
| TOTAL | $2,830 | $2,830 | $2,830 | $2,830 | $2,910 |
| Total Liabilities | $8,420 | $7,970 | $7,700 | $6,500 | $5,910 |
| Shareholders' Equity | |||||
| Common Shares | 16,480 | 16,420 | 16,420 | 16,300 | 16,300 |
| Retained earnings | -20,490 | -19,700 | -18,860 | -17,380 | -16,590 |
| Other shareholders' equity | 30 | 30 | 30 | 40 | 10 |
| TOTAL | $-320 | $250 | $1,090 | $2,460 | $3,220 |
| Total Liabilities And Equity | $8,100 | $8,220 | $8,790 | $8,960 | $9,130 |